NCT Dresden

NCT Dresden in brief

The National Center for Tumor Diseases (NCT) was established in Dresden in 2015 as a partner site of NCT Heidelberg.

NCT Dresden is a joint institution of the German Cancer Research Center, the Carl Gustav Carus Faculty of Medicine at TU Dresden, the University Hospital Carl Gustav Carus Dresden and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). It combines interdisciplinary patient care with excellent cancer research beneath the same roof.

Aim

We want to translate promising concepts from cancer research into patient care and cancer prevention, in order to stimulate studies and to develop new treatment and prevention strategies. The aim is to develop an individualized cancer medicine with targeted therapies for each individual patient.

History of cancer research and treatment in Dresden

2003
Founding of the University Cancer Center (UCC) as a multidisciplinary center for tumor treatment, cancer research and education.

2004 
The "OncoRay - Center for Radiation Research in Oncology" is included in the funding program "Centers for Innovation Competence: Create Excellence - Foster Talents" by the Federal Ministry of Education and Research (BMBF)

2005
Start of the Collaborative Research Center 655: "Cells into tissues: Stem cell and progenitor commitment and interactions during tissue formation"

2007

UCC is awarded the title "Oncological Center of Excellence" by the German Cancer Aid. This award has been renewed with every assessment ever since.

2010
Germany's first partner site of the Cancer Information Service (KID) by the German Cancer Research Center (DKFZ) is established in Dresden.

OncoRay is named "National Center for Radiation Research in Oncology" jointly with the Heidelberg Institute for Radiooncology (HIRO)

2012
Dresden becomes a partner of the German Cancer Consortium.

2014
The Federal Minister of Research announces Dresden to be the partner site of NCT Heidelberg.

2015
The establishment of NCT Dresden begins.

Patient Care

Patient care at the NCT site Dresden is in the hands of the University Cancer Center (UCC) and the participating clinics with physicians and nurses from the University Hospital Carl Gustav Carus. Certified organ cancer centers ensure the high quality of treatment.

Visit the UCC website

Clinical Trials

  • currently more than 170 oncological clinical studies
  • 18 percent of our cancer patients are participating in clinical studies

Research

Forschung im NCT Dresden

Research at NCT Dresden focusses on high-precision radiotherapy, novel surgery methods, modern cancer medication, biological imaging methods and molecular tumor diagnostics. As part of a development program these research areas will be extended and reinforced.

Quality

  • evidence-based guidelines for diagnostics, therapy and post-therapy
  • up to 17 interdisciplinary tumor boards weekly
  • core units:
    NCT Unit for Molecular Tumor Diagnostics, NCT Data and Trial Management Unit, NCT Immune Monitoring Unit

Directorate

The directorate of NCT Dresden consists of 13 directors.

Professor Dr. Martin Bornhäuser

Contact

Tel.: +49 (0)351 458 4704
E-Mail: martin.bornhaeuser(at)uniklinikum-dresden.de

Contact

Phone: +49 (0)351 458 5531
E-Mail: hanno.glimm(at)nct-dresden.de

Professor Dr. Jürgen Weitz im NCT Dresden

Contact

Tel.: +49 (0)351 458 2742
Fax: +49 (0)351 458 4395
E-Mail: juergen.weitz(at)uniklinikum-dresden.de

Professor Dr. Michael Baumann im NCT Dresden

Contact

Tel.: +49 (0)6221 42 2163
E-Mail: michael.baumann(at)dkfz-heidelberg.de

Dr. Heidrun Groß

Dr. Heidrun Groß

Head of the coordination office NCT Dresden

Fetscherstraße 74/PF 41
01307 Dresden
Tel.: +49 (0)351 458 5239
Fax: +49 (0)351 458 5716
E-Mail: h.gross(at)dkfz.de